U-M Division of Rheumatology Researchers

Innovative research conducted by our faculty and staff have paved the way for more effective methods of prevention, diagnosis, and treatment of rheumatic diseases.

Research Highlights

Studying an Extra COVID-19 Vaccine Dose in People with Autoimmune Diseases

Dinesh Khanna, MD, MSc co-leads a National Institutes of Health study that will examine the antibody response to an additional dose of the COVID-19 vaccine in people with autoimmune diseases.

For Psoriasis, Targeting Skin Protein May Help Control Inflammation

Mehrnaz Gharaee-Kermani, DVM, MPH, PhD; J. Michelle Kahlenberg, MD, PhD; and team find that psoriasis became more severe when more interferon kappa was present.

Higher CTRP9 Linked to Worse Pulmonary Function in SSc-Related Interstitial Lung Disease

The publication "Circulating CTRP9 Is Associated with Severity of Systemic Sclerosis-Associated Interstitial Lung Disease", with author John Varga, MD, is featured in Healio Rheumatology.

Novel Autoantibody Adds Fuel to COVID-19 “Firestorm” of Inflammation, Blood Clots

Ray Zuo, MD; Yogen Kanthi, MD; Jason Knight, MD, PhD; and team analyze serum from hospitalized COVID patients and find that those with higher levels of anti-NET antibodies were more likely to develop severe COVID symptoms.

There Are More Immunocompromised Americans Than We Think, and That’s a Problem with COVID-19 Vaccines

Beth Wallace, MD, MSc and team find that people who take immune-weakening drugs could be at an increased risk of COVID-related hospitalization.